GlassScriptPhysician profile
Tara S Harris
NPI 1851575930
$1,644.60
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $351 · 2022: $445 · 2023: $278 · 2024: $413 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $677.55 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $225.62 | 2023-2024 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Abbott Laboratories | $119.54 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| E.R. Squibb & Sons, L.L.C. | $118.52 | 2025 | Cobenfy |
| Urovant Sciences INC | $102.60 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.70 | 2021-2022 | |
| Abbvie INC. | $64.28 | 2021-2024 | |
| Eisai INC. | $34.93 | 2024 | |
| Dexcom, INC. | $34.33 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $34.33 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $31.31 | 2021 | |
| Amarin Pharma, INC. | $29.02 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.90 | 2022 | |
| Corium, LLC | $17.40 | 2024 | Azstarys |
| Phadia US INC. | $16.07 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.81 | 2023 | Repatha, Otezla |
| Axsome Therapeutics, INC. | $15.40 | 2024 | Sunosi |
| Glaxosmithkline, LLC. | $13.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.